Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 4/2009

01-12-2009

Hormone-Responsive Model of Primary Human Breast Epithelium

Authors: J. Dinny Graham, Patricia A. Mote, Usha Salagame, Rosemary L. Balleine, Lily I. Huschtscha, Christine L. Clarke

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 4/2009

Login to get access

Abstract

Retention of hormone responsiveness in primary culture models of human breast is essential for studies aimed at understanding the mechanisms of action of the ovarian hormones in the human breast. In this chapter we describe the development of a culture model of primary human breast that retains critical features of the tissue in vivo. We find that primary normal human breast tissue in embedded culture recapitulates the morphology, cell lineages, functional gene expression characteristics and estrogen and progesterone receptor responsiveness of the breast in vivo. The ratio of luminal to myoepithelial cells after culture recapitulates that observed in the uncultured tissue, highlighting the fact that progenitor cells capable of giving rise to both epithelial cell lineages are retained in this model system. By contrast, primary cells placed into monolayer culture, even for a single passage, lose bipotent progenitors, and the myoepithelial lineage predominates, demonstrating the rapidity with which phenotypic changes and selection occur in normal breast cells, unless cultured under conditions that prevent this outcome. Primary matrix-embedded culture of normal human breast cells provides researchers with a new opportunity to understand ovarian hormone action in the human breast.
Literature
1.
go back to reference Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biology Neoplasia. 2000;5:119–37.CrossRef Howard BA, Gusterson BA. Human breast development. J Mammary Gland Biology Neoplasia. 2000;5:119–37.CrossRef
2.
go back to reference Ismail PM, Amato P, Soyal SM, et al. Progesterone involvement in breast development and tumorigenesis–as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids. 2003;68(10–13):779–87.CrossRefPubMed Ismail PM, Amato P, Soyal SM, et al. Progesterone involvement in breast development and tumorigenesis–as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids. 2003;68(10–13):779–87.CrossRefPubMed
3.
go back to reference Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20(3):358–417.CrossRefPubMed Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20(3):358–417.CrossRefPubMed
4.
go back to reference Santen RJ. Risk of breast cancer with progestins: critical assessment of current data. Steroids. 2003;68(10–13):953–64.CrossRefPubMed Santen RJ. Risk of breast cancer with progestins: critical assessment of current data. Steroids. 2003;68(10–13):953–64.CrossRefPubMed
5.
go back to reference Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biology Neoplasia. 1998;3:23–35.CrossRef Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biology Neoplasia. 1998;3:23–35.CrossRef
6.
go back to reference Lakhani SR, O’Hare MJ. The mammary myoepithelial cell—Cinderella or ugly sister? Breast Cancer Res. 2001;3:1–4.CrossRefPubMed Lakhani SR, O’Hare MJ. The mammary myoepithelial cell—Cinderella or ugly sister? Breast Cancer Res. 2001;3:1–4.CrossRefPubMed
7.
go back to reference Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36(Suppl 1):59–72.CrossRefPubMed Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36(Suppl 1):59–72.CrossRefPubMed
8.
go back to reference Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39–50.PubMed Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39–50.PubMed
9.
go back to reference Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4(5):197–201.CrossRefPubMed Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002;4(5):197–201.CrossRefPubMed
10.
go back to reference Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol. 2005;15(5):342–52.CrossRefPubMed Nelson CM, Bissell MJ. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol. 2005;15(5):342–52.CrossRefPubMed
11.
go back to reference Humason G. Animal tissue techniques. 4th ed. San Francisco: WH Freeman & Co; 1979. Humason G. Animal tissue techniques. 4th ed. San Francisco: WH Freeman & Co; 1979.
12.
go back to reference Rosen PP. Breast pathology. Philadelphia: Lippincott-Raven; 1997. Rosen PP. Breast pathology. Philadelphia: Lippincott-Raven; 1997.
13.
go back to reference Graham JD, Mote PA, Salagame U, et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009;150(7):3318–26.CrossRefPubMed Graham JD, Mote PA, Salagame U, et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009;150(7):3318–26.CrossRefPubMed
14.
go back to reference Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002;72(2):163–72.CrossRefPubMed Mote PA, Bartow S, Tran N, Clarke CL. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat. 2002;72(2):163–72.CrossRefPubMed
15.
go back to reference Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35.PubMed Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35.PubMed
16.
go back to reference Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed
Metadata
Title
Hormone-Responsive Model of Primary Human Breast Epithelium
Authors
J. Dinny Graham
Patricia A. Mote
Usha Salagame
Rosemary L. Balleine
Lily I. Huschtscha
Christine L. Clarke
Publication date
01-12-2009
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 4/2009
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-009-9160-6

Other articles of this Issue 4/2009

Journal of Mammary Gland Biology and Neoplasia 4/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine